EUDA Health Holdings Limited(EUDA)

Medical - Care Facilities · Singapore, CE

$17.62+0.32 (+1.85%)

Delayed quote: Oct 6, 2026, 3:54 PM EDT

EUDA Health Holdings (EUDA) PE Ratio: History & Chart | TGMCharts

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T19:56:40.750Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:56:40.750Z.

Quote observation: 2026-10-06T19:54:59.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 17.62
Unrounded diluted TTM EPS · period ending 2025-12-31: -2.558

FMP input reference: c8d7801cb5d69976804150322740a3f9972799eb944d256c77d6faa31d53dc8f

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

EUDA PE Ratio Metrics

PE RATIO

N/A

EUDA Competitors' PE Ratio

EUDA

EUDA Health Holdings Limited

Current

Market Cap

$32.91M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EDSA

Edesa Biotech, Inc.

vs EUDA

Market Cap

$36.08M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELTX

Elicio Therapeutics, Inc.

vs EUDA

Market Cap

$35.66M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QTI

QT Imaging Holdings, Inc.

vs EUDA

Market Cap

$35.39M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BCTX

BriaCell Therapeutics Corp.

vs EUDA

Market Cap

$35.06M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCGO

DocGo Inc.

vs EUDA

Market Cap

$35.03M

PE Ratio

N/A

TTM Avg

14.70

3Y Avg

37.22

5Y Avg

37.36

NEPH

Nephros, Inc.

vs EUDA

Market Cap

$36.15M

PE Ratio

20.98

TTM Avg

36.35

3Y Avg

61.12

5Y Avg

61.12

IXHL

Incannex Healthcare Limited

vs EUDA

Market Cap

$37.87M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HBIO

Harvard Bioscience, Inc.

vs EUDA

Market Cap

$38.34M

PE Ratio

N/A

TTM Avg

328.93

3Y Avg

271.56

5Y Avg

151.89

ELUT

Elutia Inc

vs EUDA

Market Cap

$34.04M

PE Ratio

0.82

TTM Avg

1.13

3Y Avg

1.13

5Y Avg

1.13

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
EUDA Health Holdings Limited (EUDA)	$32.91M	N/A	N/A	N/A	N/A
Edesa Biotech, Inc. (EDSA)vs ›	$36.08M	N/A	N/A	N/A	N/A
Elicio Therapeutics, Inc. (ELTX)vs ›	$35.66M	N/A	N/A	N/A	N/A
QT Imaging Holdings, Inc. (QTI)vs ›	$35.39M	N/A	N/A	N/A	N/A
BriaCell Therapeutics Corp. (BCTX)vs ›	$35.06M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$35.03M	N/A	14.70	37.22	37.36
Nephros, Inc. (NEPH)vs ›	$36.15M	20.98	36.35	61.12	61.12
Incannex Healthcare Limited (IXHL)vs ›	$37.87M	N/A	N/A	N/A	N/A
Harvard Bioscience, Inc. (HBIO)vs ›	$38.34M	N/A	328.93	271.56	151.89
Elutia Inc (ELUT)vs ›	$34.04M	0.82	1.13	1.13	1.13

P/E Comparison

Trailing P/E

N/A

Forward P/E

11.0

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$17.62

Forward EPS (Est.)

$1.60

Forward P/E

11.01

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

EUDA PE Ratio Metrics

EUDA Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics